Michael P. Spears - 04 Nov 2022 Form 4 Insider Report for INSULET CORP (PODD)

Signature
/s/ Patricia K. Dolan, attorney-in-fact
Issuer symbol
PODD
Transactions as of
04 Nov 2022
Net transactions value
-$3,929,462
Form type
4
Filing time
07 Nov 2022, 15:13:15 UTC
Previous filing
02 Mar 2022
Next filing
13 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PODD Common Stock Options Exercise $290,724 +6,290 +39% $46.22* 22,450 04 Nov 2022 Direct F1
transaction PODD Common Stock Sale $4,220,185 -13,658 -61% $308.99 8,792 04 Nov 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PODD Employee Stock Option (Right to Buy) Options Exercise $0 -6,290 -37% $0.000000 10,768 04 Nov 2022 Common Stock 6,290 $46.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
F2 The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $306.38 to $320. Specifically:7,368 shares were sold at a price of $306.38; 5,000 shares were sold at a price of $310; and 1,290 shares were sold at a price of $320. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3 This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.